Health & Safety Industry Today

Allergic Rhinitis Market: Epidemiology, Trends, Share, Size 2023-2033

The elevating prevalence of allergic reactions to numerous allergens, such as pollen, mold, pet dander, dust mites, etc.
Published 21 August 2023

The report offers a comprehensive analysis of the allergic rhinitis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the myasthenia gravis market.

Request for a Sample Copy of this Report:

The elevating prevalence of allergic reactions to numerous allergens, such as pollen, mold, pet dander, dust mites, etc., is primarily augmenting the allergic rhinitis market. Additionally, the rising utilization of topical nasal corticosteroids, as they aid in reducing inflammation in the nasal passages and alleviate symptoms, including runny nose, congestion, sneezing, etc., is further propelling the market growth. Besides this, the growing adoption of rhinomanometry, which measures the resistance of airflow through the nasal passages to identify any blockages or narrowing that may be causing the ailment, is acting as another significant growth-inducing factor. Furthermore, the continuous advancements in drug delivery systems, including nasal sprays and inhalers, which improve the efficacy and convenience of treatment for allergic rhinitis patients, are positively influencing the market growth. Apart from this, the increasing application of the basophil activation test, which minimizes the requirement for in-vivo procedures and specifically detects all the characteristics of IgE and allergens in the diagnosis of allergic disease, is projected to fuel the allergic rhinitis market over the forecasted period.

Countries Covered:

  • United States
  • • Germany
  • • France
  • • United Kingdom
  • • Italy
  • • Spain
  • • Japan

Analysis Covered Across Each Country:

  • Historical, current, and future epidemiology scenario
  • • Historical, current, and future performance of the allergic rhinitis market
  • • Historical, current, and future performance of various therapeutic categories in the market
  • • Sales of various drugs across the allergic rhinitis market
  • • Reimbursement scenario in the market
  • • In-market and pipeline drugs

This report also provides a detailed analysis of the current allergic rhinitis marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

  • Drug Overview
  • • Mechanism of Action
  • • Regulatory Status
  • • Clinical Trial Results
  • • Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

  • Drug overview
  • • Mechanism of action
  • • Regulatory status
  • • Clinical trial results
  • • Drug uptake and market performance

Competitive Landscape With Key Players:

The competitive landscape of the allergic rhinitis market has been studied in the report with the detailed profiles of the key players operating in the market.

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures:

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

Company Name: IMARC Group

Contact Person: Elena Anderson


Phone: +1-631-791-1145

Address: 134 N 4th St

City: Brooklyn

State: NY

Country: United States


Other Industry News

Ready to start publishing

Sign Up today!